EDIT : Editas Medicine stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
year | Average | Low | High | Change from close on 2024-09-06 |
---|---|---|---|---|
2024 | $3.73 | $3.65 | $3.82 | 3.94% |
2025 | $4.05 | $3.89 | $4.38 | 12.91% |
2026 | $5.24 | $4.49 | $6.07 | 45.85% |
2027 | $7.23 | $6.26 | $8.11 | 101.36% |
2028 | $8.4 | $8.21 | $8.47 | 133.98% |
2029 | $7.81 | $7.32 | $8.09 | 117.5% |
2030 | $5.85 | $4.47 | $7.15 | 62.86% |
2031 | $4.16 | $3.57 | $4.39 | 15.76% |
2032 | $3.04 | $2.83 | $3.42 | -15.26% |
2033 | $2.68 | $2.6 | $2.8 | -25.21% |
2034 | $2.56 | $2.54 | $2.59 | -28.61% |
The 8 Wall Street analysts offering Editas Medicine stock forecast in the last 6 months have average price target of
$10.5 with a high forecast of $15.0 and a low forecast of $7.0.
The average Editas Medicine stock forecast represents a 192.48%
increase from the last price of $3.58999991416931.
For Editas Medicine stock forecast for 2024, 3 predictions are offered for each month of 2024 with average Editas Medicine stock
forecast of $3.73, a high forecast of $3.82, and a low forecast of $3.65.
The average Editas Medicine stock forecast 2024 represents a 3.94%
increase from the last price of $3.58999991416931.
For Editas Medicine stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Editas Medicine stock
forecast of $4.05, a high forecast of $4.38, and a low forecast of $3.89.
The average Editas Medicine stock forecast 2025 represents a 12.91%
increase from the last price of $3.58999991416931.
For Editas Medicine stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Editas Medicine stock
forecast of $7.23, a high forecast of $8.11, and a low forecast of $6.26.
The average Editas Medicine stock forecast 2027 represents a 101.36%
increase from the last price of $3.58999991416931.
For Editas Medicine stock forecast for 2029 (5 year), 12 predictions are offered for each month of 2029 with average Editas Medicine stock
forecast of $7.81, a high forecast of $8.09, and a low forecast of $7.32.
The average Editas Medicine stock forecast 2029 represents a 117.5%
increase from the last price of $3.58999991416931.
For Editas Medicine stock forecast 2030, 12 predictions are offered for each month of 2030 with average Editas Medicine stock
forecast of $5.85, a high forecast of $7.15, and a low forecast of $4.47.
The average Editas Medicine stock forecast 2030 represents a 62.86%
increase from the last price of $3.58999991416931.
For Editas Medicine stock forecast for 2034 (10 year), 9 predictions are offered for each month of 2034 with average Editas Medicine stock
forecast of $2.56, a high forecast of $2.59, and a low forecast of $2.54.
The average Editas Medicine stock forecast 2034 represents a -28.61%
decrease from the last price of $3.58999991416931.
Please, see more forecasts below.
EDIT : Editas Medicine stock forecast by Wall Street Analysts
The average Editas Medicine stock forecast from last 6 month is $10.5, and this show a -19.77% decrease in average from the prior price target of the each prediction. Also, this average forecast of $10.5 represents a -20.75% decrease from the past average forecast of $13.25, 6 months ago from 8 wall street analysts.
Date | Firm | previous price target | current price target | current rating |
---|---|---|---|---|
2024-08-08 | B of A Securities | $13.0000 | $15 | Buy |
2024-08-08 | Truist Securities | $20.00 | $12 | Buy |
2024-08-08 | Barclays | $9.00 | $7.0000 | Equal-Weight |
2024-06-18 | Oppenheimer | $12.0000 | $12 | Perform |
2024-05-30 | Evercore ISI Group | $15.0000 | $7.0000 | In-Line |
2024-05-09 | Barclays | $11.0000 | $9.0000 | Equal-Weight |
2024-05-09 | Morgan Stanley | $7 | Equal-Weight | |
2024-05-09 | Citigroup | $16.00 | $15.0000 | Buy |
2024-02-29 | Barclays | $10.0000 | $11.0000 | Equal-Weight |
2024-02-29 | Citigroup | $11.00 | $16 | Buy |
2024-02-27 | JP Morgan | $8.00 | $9 | Neutral |
2023-12-12 | Truist Securities | $15.0000 | $20.0000 | Buy |
2023-10-24 | Citigroup | $11.0000 | Buy | |
2023-10-18 | JP Morgan | $8.0000 | Neutral | |
2023-10-17 | Cantor Fitzgerald | Neutral | ||
2023-09-29 | Stifel | $9.0000 | $17.0000 | Buy |
2023-09-13 | Cantor Fitzgerald | $14.0000 | Overweight |
Editas Medicine stock forecast for upcoming days
Date | Price Target | Change |
---|---|---|
2024-09-09 | $3.49 | -2.70% |
2024-09-10 | $3.64 | 4.16% |
2024-09-11 | $3.53 | -2.89% |
2024-09-12 | $4.06 | 15.01% |
2024-09-13 | $4.25 | 4.53% |
EDIT : Long term Editas Medicine stock forecast for 2024 - 2025 - 2030
Forecast for 2024 Oct. is $3.65 , for 2025 Sep. is $4.10 , for 2028 Sep. is $8.46 , for 2029 Sep. is $7.68 , for 2033 Sep. is $2.63 , and for 2034 Sep. is $2.54.
EDIT : Editas Medicine stock forecast for 2024
Date | Price Target | Change |
---|---|---|
2024 Oct. | $3.65 | 1.65% |
2024 Nov. | $3.73 | 2.10% |
2024 Dec. | $3.82 | 2.52% |
EDIT : Editas Medicine stock forecast for 2025
Date | Price Target | Change |
---|---|---|
2025 Jan. | $3.89 | 1.74% |
2025 Feb. | $3.93 | 1.07% |
2025 Mar. | $3.95 | 0.55% |
2025 Apr. | $3.96 | 0.25% |
2025 May. | $3.97 | 0.22% |
2025 Jun. | $3.98 | 0.35% |
2025 Jul. | $4.01 | 0.66% |
2025 Aug. | $4.04 | 0.87% |
2025 Sep. | $4.10 | 1.35% |
2025 Oct. | $4.17 | 1.86% |
2025 Nov. | $4.27 | 2.29% |
2025 Dec. | $4.38 | 2.46% |
EDIT : Editas Medicine stock forecast for 2026
Date | Price Target | Change |
---|---|---|
2026 Jan. | $4.49 | 2.70% |
2026 Feb. | $4.62 | 2.79% |
2026 Mar. | $4.75 | 2.74% |
2026 Apr. | $4.88 | 2.82% |
2026 May. | $5.01 | 2.71% |
2026 Jun. | $5.15 | 2.71% |
2026 Jul. | $5.28 | 2.63% |
2026 Aug. | $5.42 | 2.58% |
2026 Sep. | $5.56 | 2.64% |
2026 Oct. | $5.72 | 2.75% |
2026 Nov. | $5.88 | 2.96% |
2026 Dec. | $6.07 | 3.12% |
EDIT : Editas Medicine stock forecast for 2027
Date | Price Target | Change |
---|---|---|
2027 Jan. | $6.26 | 3.10% |
2027 Feb. | $6.44 | 2.97% |
2027 Mar. | $6.63 | 2.86% |
2027 Apr. | $6.81 | 2.79% |
2027 May. | $6.99 | 2.63% |
2027 Jun. | $7.17 | 2.53% |
2027 Jul. | $7.34 | 2.40% |
2027 Aug. | $7.51 | 2.31% |
2027 Sep. | $7.68 | 2.23% |
2027 Oct. | $7.84 | 2.12% |
2027 Nov. | $7.99 | 1.88% |
2027 Dec. | $8.11 | 1.51% |
EDIT : Editas Medicine stock forecast for 2028
Date | Price Target | Change |
---|---|---|
2028 Jan. | $8.21 | 1.30% |
2028 Feb. | $8.31 | 1.19% |
2028 Mar. | $8.38 | 0.90% |
2028 Apr. | $8.43 | 0.52% |
2028 May. | $8.45 | 0.27% |
2028 Jun. | $8.46 | 0.11% |
2028 Jul. | $8.46 | -0.01% |
2028 Aug. | $8.46 | -0.03% |
2028 Sep. | $8.46 | -0.00% |
2028 Oct. | $8.46 | -0.00% |
2028 Nov. | $8.47 | 0.12% |
2028 Dec. | $8.26 | -2.45% |
EDIT : Editas Medicine stock forecast for 2029
Date | Price Target | Change |
---|---|---|
2029 Jan. | $8.09 | -2.08% |
2029 Feb. | $8.06 | -0.34% |
2029 Mar. | $8.03 | -0.35% |
2029 Apr. | $8.00 | -0.44% |
2029 May. | $7.95 | -0.55% |
2029 Jun. | $7.90 | -0.65% |
2029 Jul. | $7.84 | -0.77% |
2029 Aug. | $7.77 | -0.91% |
2029 Sep. | $7.68 | -1.08% |
2029 Oct. | $7.59 | -1.29% |
2029 Nov. | $7.47 | -1.57% |
2029 Dec. | $7.32 | -1.92% |
EDIT : Editas Medicine stock forecast for 2030
Date | Price Target | Change |
---|---|---|
2030 Jan. | $7.15 | -2.32% |
2030 Feb. | $6.96 | -2.72% |
2030 Mar. | $6.74 | -3.17% |
2030 Apr. | $6.50 | -3.56% |
2030 May. | $6.24 | -3.91% |
2030 Jun. | $6.00 | -3.98% |
2030 Jul. | $5.76 | -3.92% |
2030 Aug. | $5.53 | -4.07% |
2030 Sep. | $5.24 | -5.08% |
2030 Oct. | $4.92 | -6.14% |
2030 Nov. | $4.65 | -5.62% |
2030 Dec. | $4.47 | -3.74% |
EDIT : Editas Medicine stock forecast for 2031
Date | Price Target | Change |
---|---|---|
2031 Jan. | $4.39 | -1.77% |
2031 Feb. | $4.37 | -0.50% |
2031 Mar. | $4.38 | 0.08% |
2031 Apr. | $4.38 | 0.13% |
2031 May. | $4.37 | -0.21% |
2031 Jun. | $4.33 | -0.88% |
2031 Jul. | $4.26 | -1.71% |
2031 Aug. | $4.16 | -2.34% |
2031 Sep. | $4.03 | -3.02% |
2031 Oct. | $3.89 | -3.64% |
2031 Nov. | $3.73 | -4.07% |
2031 Dec. | $3.57 | -4.23% |
EDIT : Editas Medicine stock forecast for 2032
Date | Price Target | Change |
---|---|---|
2032 Jan. | $3.42 | -4.09% |
2032 Feb. | $3.30 | -3.72% |
2032 Mar. | $3.19 | -3.16% |
2032 Apr. | $3.11 | -2.53% |
2032 May. | $3.05 | -1.94% |
2032 Jun. | $3.01 | -1.47% |
2032 Jul. | $2.97 | -1.15% |
2032 Aug. | $2.94 | -0.97% |
2032 Sep. | $2.92 | -0.91% |
2032 Oct. | $2.89 | -0.93% |
2032 Nov. | $2.86 | -0.97% |
2032 Dec. | $2.83 | -1.00% |
EDIT : Editas Medicine stock forecast for 2033
Date | Price Target | Change |
---|---|---|
2033 Jan. | $2.80 | -1.02% |
2033 Feb. | $2.78 | -1.00% |
2033 Mar. | $2.75 | -0.97% |
2033 Apr. | $2.72 | -0.91% |
2033 May. | $2.70 | -0.83% |
2033 Jun. | $2.68 | -0.75% |
2033 Jul. | $2.66 | -0.67% |
2033 Aug. | $2.65 | -0.59% |
2033 Sep. | $2.63 | -0.53% |
2033 Oct. | $2.62 | -0.47% |
2033 Nov. | $2.61 | -0.41% |
2033 Dec. | $2.60 | -0.37% |
EDIT : Editas Medicine stock forecast for 2034
Date | Price Target | Change |
---|---|---|
2034 Jan. | $2.59 | -0.34% |
2034 Feb. | $2.58 | -0.33% |
2034 Mar. | $2.58 | -0.32% |
2034 Apr. | $2.57 | -0.31% |
2034 May. | $2.56 | -0.29% |
2034 Jun. | $2.55 | -0.26% |
2034 Jul. | $2.55 | -0.21% |
2034 Aug. | $2.54 | -0.17% |
2034 Sep. | $2.54 | -0.12% |
Frequently Asked Questions about Editas Medicine stock forecast
Is Editas Medicine a good long term stock?
From Editas Medicine stock forecast , Editas Medicine (EDIT) stock can be a good investment choice. According to AIPickup, the Editas Medicine stock price forecast for 2024 Oct. is $3.6492236348573 From Editas Medicine stock forecast , Editas Medicine (EDIT) stock can be a good investment choice. According to AIPickup, the Editas Medicine stock price forecast for 2025 Sep. is $4.09805573531696 From Editas Medicine stock forecast , Editas Medicine (EDIT) stock can be a good investment choice. According to AIPickup, the Editas Medicine stock price forecast for 2028 Sep. is $8.45662438780041 From Editas Medicine stock forecast , Editas Medicine (EDIT) stock can be a good investment choice. According to AIPickup, the Editas Medicine stock price forecast for 2029 Sep. is $7.68497232750224 From Editas Medicine stock forecast , Editas Medicine (EDIT) stock cannot be a good investment choice. According to AIPickup, the Editas Medicine stock price forecast for 2033 Sep. is $2.63391830439802 From Editas Medicine stock forecast , Editas Medicine (EDIT) stock cannot be a good investment choice. According to AIPickup, the Editas Medicine stock price forecast for 2034 Sep. is $2.54065964149415
Is Editas Medicine stock overvalued?
Editas Medicine (EDIT) stock is expected to go UP . Therefore, AIPickup would say that Editas Medicine (EDIT) stock is NOT overvalued.
Will Editas Medicine stock price go up?
Yes. The Editas Medicine stock price forecast for 2025 Sep. is $4.09805573531696
Is Editas Medicine stock a good buy now?
Since closing price on 2024-09-06 is $3.58999991416931 and forecast for 2025 Sep. is $4.10, Editas Medicine stock is a good 1 year investment.
14 Days Historical Data for Editas Medicine stock price
Date | Close | Open | Low | High |
---|---|---|---|---|
EDIT stock price for 2024-08-19 | $4.10 | $4.01 | $3.99 | $4.19 |
EDIT stock price for 2024-08-20 | $3.96 | $4.13 | $3.90 | $4.13 |
EDIT stock price for 2024-08-21 | $4.08 | $4.01 | $3.95 | $4.15 |
EDIT stock price for 2024-08-22 | $3.79 | $4.08 | $3.78 | $4.08 |
EDIT stock price for 2024-08-23 | $3.87 | $3.82 | $3.77 | $4.00 |
EDIT stock price for 2024-08-26 | $3.92 | $3.90 | $3.85 | $3.99 |
EDIT stock price for 2024-08-27 | $3.82 | $3.88 | $3.72 | $3.93 |
EDIT stock price for 2024-08-28 | $3.68 | $3.78 | $3.62 | $3.81 |
EDIT stock price for 2024-08-29 | $3.71 | $3.72 | $3.67 | $3.79 |
EDIT stock price for 2024-08-30 | $3.74 | $3.75 | $3.65 | $3.78 |
EDIT stock price for 2024-09-03 | $3.49 | $3.73 | $3.46 | $3.77 |
EDIT stock price for 2024-09-04 | $3.50 | $3.47 | $3.40 | $3.56 |
EDIT stock price for 2024-09-05 | $3.49 | $3.50 | $3.42 | $3.55 |
EDIT stock price for 2024-09-06 | $3.59 | $3.49 | $3.40 | $3.62 |